Page last updated: 2024-08-26

1,2-distearoylphosphatidylethanolamine and 2019 Novel Coronavirus Disease

1,2-distearoylphosphatidylethanolamine has been researched along with 2019 Novel Coronavirus Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Ankenbruck, N; Cai, X; Chang, EB; Chen, M; Fung, J; Huang, J; Lin, Y; Missiakas, D; Nguyen, M; Penaloza-MacMaster, P; Prominski, A; Randall, G; Rosenberg, J; Shi, J; Tian, B; Tomatsidou, A1

Other Studies

1 other study(ies) available for 1,2-distearoylphosphatidylethanolamine and 2019 Novel Coronavirus Disease

ArticleYear
A Multifunctional Neutralizing Antibody-Conjugated Nanoparticle Inhibits and Inactivates SARS-CoV-2.
    Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2022, Volume: 9, Issue:2

    Topics: Angiotensin-Converting Enzyme 2; Animals; Antibodies, Neutralizing; Antibodies, Viral; Antigen-Antibody Reactions; COVID-19; Drug Evaluation, Preclinical; Hot Temperature; Humans; Immunoconjugates; Light; Mice; Nanoparticles; Phosphatidylethanolamines; Polyethylene Glycols; Polymers; Receptors, Virus; SARS-CoV-2; Semiconductors; Spike Glycoprotein, Coronavirus; Thiadiazoles; Virus Inactivation

2022